Literature DB >> 4318047

Ampicillin levels in sputum, serum, and saliva.

S M Stewart, M Fisher, J E Young, W Lutz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4318047      PMCID: PMC472702          DOI: 10.1136/thx.25.3.304

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  8 in total

1.  AMPICILLIN IN THE TREATMENT OF HAEMOPHILUS INFLUENZAE INFECTIONS OF THE RESPIRATORY TRACT.

Authors:  J R MAY; D M DELVES
Journal:  Thorax       Date:  1964-07       Impact factor: 9.139

2.  PENICILLIN LEVELS IN SPUTUM.

Authors:  F F HAFEZ; S M STEWART; M E BURNET
Journal:  Thorax       Date:  1965-05       Impact factor: 9.139

3.  Absorption and excretion of "Penbritin".

Authors:  E T KNUDSEN; G N ROLINSON; S STEVENS
Journal:  Br Med J       Date:  1961-07-22

4.  The mucosal epithelium of the respiratory tract in muco-purulent bronchitis caused by Haemophilus influenzae.

Authors:  J F HERS; J MULDER
Journal:  J Pathol Bacteriol       Date:  1953-07

5.  Concentration of penicillin in the lungs. Effects of two penicillin esters in chronic pulmonary infections.

Authors:  A G S HEATHCOTE; E NASSAU
Journal:  Lancet       Date:  1951-06-09       Impact factor: 79.321

6.  "Indirect pathogenicity" of penicillinase-producing enterobacteria in chronic bronchial infections.

Authors:  J L Maddocks; J R May
Journal:  Lancet       Date:  1969-04-19       Impact factor: 79.321

7.  Some principles in the chemotherapy of bacterial infections. II.

Authors:  J Crofton
Journal:  Br Med J       Date:  1969-04-26

8.  Ampicillin levels in the serum and urine of patients with impaired renal function.

Authors:  D Höffler; I Stegemann; F Scheler
Journal:  Ger Med Mon       Date:  1966-04
  8 in total
  23 in total

Review 1.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 2.  Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

3.  Effect of amoxicillin use on oral microbiota in young children.

Authors:  D Ready; H Lancaster; F Qureshi; R Bedi; P Mullany; M Wilson
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

4.  Penetration of ampicillin and sulbactam in the lower airways during respiratory infections.

Authors:  Y J Valcke; M T Rosseel; R A Pauwels; M G Bogaert; M E Van der Straeten
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  A Protocol for Functional Assessment of Whole-Protein Saturation Mutagenesis Libraries Utilizing High-Throughput Sequencing.

Authors:  Michael A Stiffler; Subu K Subramanian; Victor H Salinas; Rama Ranganathan
Journal:  J Vis Exp       Date:  2016-07-03       Impact factor: 1.355

6.  A Macrophage Infection Model to Predict Drug Efficacy Against Mycobacterium Tuberculosis.

Authors:  Kaitlyn Schaaf; Virginia Hayley; Alexander Speer; Frank Wolschendorf; Michael Niederweis; Olaf Kutsch; Jim Sun
Journal:  Assay Drug Dev Technol       Date:  2016-06-21       Impact factor: 1.738

7.  Penetration of piperacillin into bronchial mucosa and sputum.

Authors:  G E Marlin; K R Burgess; J Burgoyne; G R Funnell; M D Guinness
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

8.  Ecology of Haemophilus influenzae and Haemophilus parainfluenzae in sputum and saliva and effects of antibiotics on their distribution in patients with lower respiratory tract infections.

Authors:  J E Foweraker; N J Cooke; P M Hawkey
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 9.  Doxycycline in serum and bronchial secretions.

Authors:  B J Hartnett; G E Marlin
Journal:  Thorax       Date:  1976-04       Impact factor: 9.139

10.  Bronchial secretion levels of amikacin.

Authors:  W L Dull; M R Alexander; J E Kasik
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.